Acixone-TZ 281.25mg Injection
Marketer
Accilex Nutricorp
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Acixone-TZ 281.25mg Injection
Combiflox 281.25mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be overseen by a healthcare provider. Strictly adhere to the prescribed dosage schedule; completing the full course is vital, even with symptom improvement. Premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms immediately to your physician. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While usually non-impairing, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Uses of Acixone-TZ 281.25mg Injection
Infections caused by bacteria
Major Benefits of Acixone-TZ 281.25mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Acixone-TZ 281.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Acixone-TZ 281.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Acixone-TZ 281.25mg Injection works:
Ceftriaxone and Tazobactum, the components of Acixone-TZ 281.25mg Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Acixone-TZ 281.25mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Acixone-TZ, 281.25mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human studies remain scarce.
Breast feedingCAUTION
The administration of Acixone-TZ 281.25mg Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Acixone-TZ 281.25mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Acixone-TZ 281.25mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
The 281.25mg Acixone-TZ injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Acixone-TZ 281.25mg injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Acixone-TZ 281.25mg Injection :
Omit a dose of Acixone-TZ 281.25mg Injection? Seek medical advice immediately.
Facts to Know About Acixone-TZ 281.25mg Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Antimicrobial agents |
3,018 People bought this recently